Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

62.92
-1.1600-1.81%
Post-market: 61.27-1.6500-2.62%19:17 EST
Volume:4.74M
Turnover:302.68M
Market Cap:12.09B
PE:23.47
High:65.95
Open:64.08
Low:62.63
Close:64.08
52wk High:73.51
52wk Low:50.76
Shares:192.11M
Float Shares:178.10M
Volume Ratio:2.01
T/O Rate:2.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.68
EPS(LYR):2.21
ROE:9.07%
ROA:6.15%
PB:2.00
PE(LYR):28.51

Loading ...

Biomarin Pharmaceutical Q4 Adj. EPS $0.46 Misses $0.63 Estimate, Sales $875.000M Beat $827.969M Estimate

Benzinga
·
3 hours ago

BioMarin Q4 net income swings to a GAAP net loss of USD 47 million on 17% revenue growth to USD 875 million

Reuters
·
3 hours ago

BRIEF-Biomarin Pharmaceutical Q4 EPS USD -0.24

Reuters
·
3 hours ago

Biomarin Pharmaceutical Q4 Adjusted EPS USD 0.46 VS. Ibes Estimate USD 0.62

THOMSON REUTERS
·
3 hours ago

Biomarin Pharmaceutical Outlook FY Adj EPS $4.95 to $5.15

THOMSON REUTERS
·
3 hours ago

Biomarin Pharmaceutical Inc Outlook FY Total Revenues $3,325 Mln to $3,425 Mln

THOMSON REUTERS
·
3 hours ago

Biomarin Pharmaceutical Inc FY2026 Shr View $4.50, REV View $3.52 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
3 hours ago

BioMarin options imply 7.4% move in share price post-earnings

TIPRANKS
·
3 hours ago

BioMarin Pharmaceutical Inc expected to post earnings of 62 cents a share - Earnings Preview

Reuters
·
Feb 21

Amicus FY 2025 Pombiliti + Opfolda sales rose 57% to USD 34.97M

Reuters
·
Feb 21

BioMarin Pharmaceutical (BMRN) Receives a Buy from Bernstein

TIPRANKS
·
Feb 19

BioMarin Pharmaceutical Inc. to announce fourth quarter and full-year financial results

Reuters
·
Feb 17

BioMarin Pharmaceutical (BMRN) Receives a Buy from Canaccord Genuity

TIPRANKS
·
Feb 13

BioMarin Closes $850 Million Senior Unsecured Notes Offering

Reuters
·
Feb 13

Biomarin Announces Closing of Private Offering of Senior Notes

THOMSON REUTERS
·
Feb 13

BioMarin Pharmaceutical (BMRN) Gets a Buy from Jefferies

TIPRANKS
·
Feb 12

BridgeBio's oral drug improves growth in children with dwarfism in late-stage study

Reuters
·
Feb 12

BRIEF-Biomarin Receives Health Canada Notice Of Compliance With Conditions For Voxzogo®, For Achondroplasia

Reuters
·
Feb 11

Biomarin Receives Health Canada Notice of Compliance With Conditions for Voxzogo®, for Achondroplasia

THOMSON REUTERS
·
Feb 11

BioMarin Pharmaceutical Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Feb 07